4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-401017
Chief Executive Officer sold 2,210 shares at an average $39.17 ($86,565)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham Chief Executive Officer | 2026-09-23 | Sale 10b5-1 | −1,952 | $39.05 | $76,230 | 457,025 | D |
| Ceesay Abraham Chief Executive Officer | 2026-09-23 | Sale 10b5-1 | −215 | $39.86 | $8,570 | 456,810 | D |
| Ceesay Abraham Chief Executive Officer | 2026-09-23 | Sale 10b5-1 | −43 | $41.05 | $1,765 | 456,767 | D |
| Open-market sales · 2,210 sh · avg $39.17 · $86,565 | |||||||
Loading xslF345X06/ownership.xml…